Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7Gastrointestinal 4Thoracic 2Genitourinary 2Tumor-Agnostic 1Other hematologic neoplasm 1Other 1Lymphoid 1Head & Neck 1Gynecologic 1

Conditions

Neoplasms 1

Interventions

Drug Therapy 5Docetaxel 3Bevacizumab 3icotinib 2Vincristine 2Pemetrexed 2Misoprostol 2Genes, p53 2Gemcitabine 2Dexamethasone 2Carboplatin 2Aspirin 2pinaverium 1pentetreotide 1pembrolizumab 1pazopanib 1olaparib 1netupitant, palosentron drug combination 1nedaplatin 1lorlatinib 1durvalumab 1ceritinib 1atezolizumab 1Zoledronic Acid 1Water 1Vitamin E 1Vemurafenib 1Ultracet 1Triamcinolone 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Bupivacaine × Tumor-Agnostic × Clear all
NCT05082441 2021-10-19

Liposomal Bupivacaine in Benign Soft Tissue Tumor Resection

Samaritan Health Services

Phase 4 Unknown
140 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡